AstraZeneca, UPMC Health Plan sign risk-sharing deal for heart medicine

AstraZeneca and UPMC Health Plan have entered into what they are calling a "pioneering value-based contract" that covers the Pittsburgh-based health insurer's members who are taking Brilinta. Brilinta is a medication used to lower a patient’s chances of having another heart attack or dying from one in the 12 months following a heart attack. Under the value-based contract, the reimbursement AstraZeneca receives for its medication will be linked to cardiovascular outcomes for UPMC He alth Plan…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news